>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Submits Letter to CMS on Hospital Interpretive Guidelines

January 18, 2010

ASA Submits Letter to CMS on Hospital Interpretive Guidelines

ASA, under the leadership of President Alex Hannenberg, M.D., submitted a letter to the Centers for Medicare and Medicaid Services (CMS) today stating ASA’s perspective and concerns in regards to the December 11, 2009 revisions to the hospital interpretive guidelines that impact anesthesia services.  For a link to the interpretive guidelines,
click here.

ASA’s Letter to CMS on Hospital Interpretive Guidelines